Literature DB >> 10856909

Drug discovery and vaccine development using mixture-based synthetic combinatorial libraries.

.   

Abstract

The approaches and concepts that encompass combinatorial chemistry represent a paradigm shift in drug discovery and basic research. Viewed initially as a curiosity by the pharmaceutical industry, combinatorial chemistry approaches are now recognized as essential drug discovery tools that decrease the time taken for discovery and increase the throughput of chemical screening by as much as 1000-fold. Although the use of mixture-based synthetic combinatorial libraries was one of the first approaches presented, its inherent strengths are only recently being recognized. Numerous mixture-based libraries of peptides, peptidomimetics and heterocycles have been synthesized and deconvoluted using the positional scanning approach. Mixture-based library approaches for drug discovery and vaccine development will be reviewed herein.

Year:  2000        PMID: 10856909     DOI: 10.1016/s1359-6446(00)01513-0

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  5 in total

1.  Solid Phase Synthesis of Isoxazole and Isoxazoline-carboxamides via [2+3]-Dipolar Cycloaddition Using Resin-bound Alkynes or Alkenes.

Authors:  Sureshbabu Dadiboyena; Adel Nefzi
Journal:  Tetrahedron Lett       Date:  2012-04-18       Impact factor: 2.415

Review 2.  Pooling in high-throughput drug screening.

Authors:  Raghunandan M Kainkaryam; Peter J Woolf
Journal:  Curr Opin Drug Discov Devel       Date:  2009-05

3.  Toward targeted oral vaccine delivery systems: selection of lectin mimetics from combinatorial libraries.

Authors:  Imelda Lambkin; Clemencia Pinilla; Christa Hamashin; Lisa Spindler; Shannon Russell; Amy Schink; Rosa Moya-Castro; Gina Allicotti; Lisa Higgins; Melanie Smith; Jackie Dee; Carolyn Wilson; Richard Houghten; Daniel O'Mahony
Journal:  Pharm Res       Date:  2003-08       Impact factor: 4.200

4.  Estimation of affinities of ligands in mixtures via magnetic recovery of target-ligand complexes and chromatographic analyses: chemometrics and an experimental model.

Authors:  Xiaolan Yang; Yanling Xie; Jun Pu; Hua Zhao; Juan Liao; Yonghua Yuan; Sha Zhu; Gaobo Long; Chun Zhang; Huidong Yuan; Yiwen Chen; Fei Liao
Journal:  BMC Biotechnol       Date:  2011-05-05       Impact factor: 2.563

5.  The Multi-Leu peptide inhibitor discriminates between PACE4 and furin and exhibits antiproliferative effects on prostate cancer cells.

Authors:  Christine Levesque; Martin Fugère; Anna Kwiatkowska; Frédéric Couture; Roxane Desjardins; Sophie Routhier; Philippe Moussette; Adam Prahl; Bernard Lammek; Jon R Appel; Richard A Houghten; François D'Anjou; Yves L Dory; Witold Neugebauer; Robert Day
Journal:  J Med Chem       Date:  2012-11-14       Impact factor: 7.446

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.